Bacterial Infections

Neurological Disorders: Course and Treatment: Second Edition

Volumn , Issue , 2003, Pages 529-544

  Pfister, Hans Walter ^a   Bleck, T P ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884123562     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012125831-3/50237-9     Document Type: Chapter

References (85)

1. Al Deeb S.M., Yaqub B.A., Sharif H.S., Phadke J.G. Neurobrucellosis: Clinical characteristicst, diagnosis, and outcome. Neurology 1989, 39:498-501.
2. American Academy of Pediatrics-Committee on Infectious Disease Dexamethasone therapy for bacterial meningitis in infants and children. Pediatrics 1990, 86:130-133.
3. Andersen J., Backer V., Voldsgrard P., Skinhoj P., Wandall J.H. Acute meningococcal meningitis: Analysis of features of the disease according to the age of 255 patients. J. Infect. 1997, 34:227-235. Members of the Copenhagen Meningitis Study Group.
4. Bakken J.S., Dumler J.S. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 2000, 31:554-560.
5. Bencina D., Dovc P., Mueller-Premru M., Avsic-Zupanc T., Socan M., Beovic B., Arnex M., Narat M. Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:521-530.
6. Braun J.S., Novak R., Herzog K.H., Bodmer S.M., Cleveland J.L., Tuomanen E.I. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 1999, 5:298-302.
7. Chang C.W.J., Bleck T.P. Acute management of neurological complications. Central Nervous Infectious Diseases and Therapy 1997, 691-709. Dekker, New York. K.L. Roos (Ed.).
8. Control and Prevention of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Morb. Mortal. Wkly. Rep. 1997, 46(RR-5):1-51.
9. Dichgans M., Jäger L., Mayer T., et al. Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology 1999, 52:1003-1009.
10. DiNubile M.J., Boom W.H., Southwick F.S. Septic cortical thrombophebitis. J. Infect. Dis. 1990, 161:1216-1220.
11. Dobbins W.O. The diagnosis of Whipple's disease. N. Engl. J. Med. 1995, 332:390-392.
12. Dodge P.R., Davis H., Feigin R.D., Holmes S.J., Kaplan S.L., Jubelirer D.P., Stechenberg B.W., Hirsh S.K. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N. Engl. J. Med. 1984, 311:869-874.
13. Dodge P.R., Swartz M.N. Bacterial meningitis: A review of selected aspects. N. Engl. J. Med. 1965, 272:725-731.
14. Dodge P.R., Swartz M.N. Bacterial meningitis: A review of selected aspects. N. Engl. J. Med. 1965, 272:1003-1010.
15. Doit C., Bourrillon A., Bingen E. Childhood bacterial meningitis-bacterial epidemiology and antibiotic resistance. Presse Medicale 1998 1998, 27:1177-1182.
16. DiNubile M.J., Boom W.H., Southwick F.S. Septic cortical thrombophlebitis. J. Infect. Dis. 1990, 161:1216-1220.
17. Dumler J.S., Bakken J.S. Human ehrlichioses: Newly recognized infections transmitted by ticks. Annu. Rev. Med. 1998, 49:201-213.
18. Durand M.L., Calderwood S.B., Weber D.J., Miller S.I., Southwick F.S., Caviness V.S., Swartz M.N. Acute bacterial meningitis. A review of 493 episodes. N. Engl. J. Med. 1993, 328:21-28.
19. Ezpeleta D., Munoz-Blanco J.L., Tabernero C., Gimenez-Roldan S. Neurological complications of Mediterranean boutonneuse fever Presentation of a case of acute encephalomeningomyelitis and review of the literature. Neurologica 1999, 14:38-42.
20. Felgenhauer K., Kober D. Apurulent bacterial meningitis (compartmental leucopenia in purulent meningitis). J. Neurol. 1985, 232:157-161.
21. Fingerle V., Goodman J.L., Johnson R.C., Kurtti T.J., Munderloh U.G., Wilske B. Epidemiologic aspects of human granulocytic Ehrlichiosis in southern Germany. Wien Klin. Wochenschr. 1999, 111:1000-1004.
22. Fortnum H.M. Hearing impairment after bacterial meningitis: A review. Arch. Dis. Child. 1992, 67:1128-1133.
23. Frei K., Nadal D., Pfister H.W., Fontana A. Listeria meningitis: Identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J. Exp. Med. 1993, 178:1255-1261.
24. Gendrel D., Raymond J., Assicot M., et al. Measurement of procalcitonin levels in children with bacterial and viral memingitis. Clin. Infect. Dis. 1997, 24:1240-1242.
25. Girgis N.I., Farid Z., Mikhail I.A., Farrag I., Sultan Y., Kilpatrick M.E. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr. Infect. Dis. J. 1989, 8:848-851.
26. Grant A.C., Hunter S., Partin W.C. A case of acute monocytic ehrlichiosis with prominent neurological signs. Neurology 1997, 48:1619-1623.
27. Gucuyener K., Simsek F., Yilmaz O., Serdaroglu A. Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. Ind. J Pediatr. 2000, 67:467-469.
28. Haring H.P., Rötzer H.K., Reindl H., Berek K., Kampfl A., Pfausler B., Schmutzhard E. Time course of cerebral blood flow velocity in central nervous system infections. Arch Neurol. 1993, 50:98-101.
29. Herbay von A., Ditton H.J., Schuhmacher F., Maiwald M. Whipple's disease: Staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology 1997, 113:434-441.
30. Igarashi M., Gilmartin R.C., Gerald B., Wilburn F., Jabbour J.T. Cerebral arteritis and bacterial meningitis. Arch. Neurol. 1984, 41:531-535.
31. Kastenbauer S., Winkler F., Fesl G., Schiel X., Ostermann H., Yousry T.A., Pfister H.W. Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI finding suggest extensive myelitis. Arch. Neurol. 2001, 58:806-810.
32. Khayr W.F., Cherubin C.E., Bleck T.P. Listeriosis: Review of a protean disease. Infect. Dis. Clin. Pract. 1992, 1:291-298.
33. Kennedy W.A., Hoyt M.J., McCracken G.H. The role of corticosteroid therapy in children with pneumococcal meningitis. Am. J. Dis. Child. 1991, 145:1374-1378.
34. Koedel U., Pfister H.W. Models of experimental meningitis. Role and limitations. Infect. Dis. Clin. North Am. 1999, 13:549-577.
35. Koedel U., Pfister H.W. Oxidative stress in bacterial meningitis. Brain Pathol. 1999, 9:57-67.
36. Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: Summary of cases at the University of Helsinki and review. Clin. Inf. Dis. 1993, 17:52-57.
37. Lebel M.H., Freji B.J., Syrogiannopoulos G.A., Chrane D.F., Hoyt M.J., Stewart S.M., Kennard B.D., Olsen K.D., McCracken G.H. Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo-controlled trials. N. Engl. J. Med. 1988, 319:964-971.
38. Leib S.L., Leppert D., Clements J., Täuber M.G. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect. Immunol. 2000, 68:615-620.
39. Lerner P.I. Nocardiosis. Clin. Infect. Dis. 1996, 22:891-903.
40. Lotric-Furlan S., Petrovec M., Zupanc T.A., et al. Human granulocytic Ehrlichiosis in Europe: Clinical and laboratory findings for four patients from Slovenia. Clin. Infect. Dis. 1998, 27:424-428.
41. Louis E.D., Lynch T., Kaufmann P., Fahn S., Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann. Neurol. 1996, 40:561-568.
42. McIntyre P.B., Berkey C.S., King S., et al. Dexamethasone as adjunctive therapy in bacterial meningitis. JAMA 1997, 278:925-931.
43. Mylonakis E., Hohmann E.L., Calderwoud S.B. Central nervous system infection with Listeria monocytogenes. 33 Years' experience at a general hospital and review of 776 episodes from the literature. Medicine 1998, 77:313-336.
44. Nau R., Wellmer A., Soto A., Koch K., Schneider O., Schmidt H., Gerber J., Michel U., Brûck W. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J. Infect. Dis. 1999, 179:1557-1560.
45. Odio C.M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Saez-Llorens X., Olsen K.D., McCracken G.H. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 1991, 324:1525-1531.
46. Paris M.M., Hickey S.M., Uscher M.I., Shelton S., Olsen K.D., McCracken G.H. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 1994, 38:1320-1324.
47. Paulson O.B., Brodersen P., Hansen E.L., Kristensen H.S. Regional cerebral blood flow, cerebral metabolic rate of oxygen, and cerebrospinal fluid acid-base variables in patients with acute meningitis and with encephalitis. Acta Med. Scand. 1974, 196:191-198.
48. Pfister H.W., Borasio G.D., Dirnagl U., Bauer M., Einhäupl K.M. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992, 42:1497-1504.
49. Pfister H.W., Feiden W., Einhäupl K.M. Spectrum of complications during bacterial meningitis in adults. Arch. Neurol. 1993, 50:575-581.
50. Pfister H.W., Koedel U., Haberl R., Dirnagl U., Feiden W., Ruckdeschel G., Einhäupl K.M. Microvascular changes during the early phase of experimental bacterial meningitis. J. Cereb. Blood Flow Metab. 1990, 10:914-922.
51. Pfister H.W., Roos K.L. Bacterial meningitis. Neurocritical Care 1994, 377-397. Springer Verlag, Berlin. W. Hacke, D.F. Hanley, K.M. Einhäupl, T.P. Bleck, M.N. Diringer (Eds.).
52. Phillips E.J., Simor A.E. Bacterial meningitis in children and adults-changes in community-acquired disease may affect patient care. Postgrad. Med. 1998, 103:102.
53. Pomeroy S.L., Holmes S.J., Dodge P.R., Feigin R.D. Seizures and other neurologic sequelae of bacterial meningitis in children. N. Engl. J. Med. 1990, 323:1651-1657.
54. Quagliarello V.J., Scheld W.M. New perspectives on bacterial meningitis. Clin. Infect. Dis. 1993, 17:603-610.
55. Quagliarello V.J., Scheld W.M. Treatment of bacterial meningitis. N. Engl. J. Med. 1997, 336:708-716.
56. Raoult D., Birg M.L., La Scola B., et al. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 2000, 342:620-625.
57. Raoult D., Tissot-Dupont H., Foucoult C., Gouvernet J., Fournier P.E., Bernit E., Stein A., Nesri M., Harle J.R., Weiller P.J. Q fever 1985-1998. Clinical and epidemiologic features of 1383 infections. Medicine 2000, 79:109-123.
58. Ratnaike R.N. Whipple's disease. Postgrad. Med. J. 2000, 76:760-766.
59. Relman D.A., Schmidt T.M., MacDermott R.P., Falkow S. Identification of the uncultured bacillus of Whipple's disease. N. Engl. J. Med. 1992, 327:298-301.
60. Roos K.L. Bacterial meningitis. Central Nervous Infectious Diseases and Therapy 1997, 99-126. Dekker, New York. K.L. Roos (Ed.).
61. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., Hughes J.M. Meningococcal disease. N. Engl. J. Med. 2001, 344:1378-1388.
62. Sakai C., Takagi T., Satoh Y. Nocardia asteroides pneumonia, subcutaneous abscess and meningitis in a patient with advanced malignant lymphoma: Successful treatment based on in vitro antimicrobial susceptibility. Intern. Med. 1999, 38:683-686.
63. Schaad U.B., Lips U., Gnehm H.E., Blumberg A., Heinzer I. Dexamethasone therapy for bacterial meningitis in children. Lancet 1993, 342:457-461. Joanna Wedgwood for the Swiss Meningitis Study Group.
64. Scheld W.M. Bacterial meningitis in the patient at risk: Intrinsic risk factors and host defense mechanisms. Am. J. Med. 1984, 76(5A):193-207.
65. Scheld W.M. Drug delivery to the central nervous system: General principles and relevance to therapy for infections of the central nervous system. Rev. Infect. Dis. 1989, 11(Suppl. 7):1669-1690.
66. Scheld W.M., Dacey R.G., Winn H.R., Welsh J.E., Jane J.A., Sande M.A. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. J. Clin. Invest. 1980, 66:243-253.
67. Schuchat A., Robinson K., Wenger J.D., et al. Bacterial meningitis in the United States in 1995. Active Surveillace Team. N. Engl. J. Med. 1997, 337:970-976.
68. Sigurdardottir B., Bjornsson O.M., Jonsdottir K.E., Erlendsottir H., Gudmundsson S. Acute bacterial meningitis in adults-A 20-year overview. Arch. Intern. Med. 1997, 157:425-430.
69. Socan M., Ravnik I., Bencina D., Dovc P., Zakotnik B., Jazbec J. Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin. Infect. Dis. 2001, 32:E31-E35.
70. Southwick F.S. Septic thrombophlebitis of major dural venous sinuses. Curr. Clin. Trop. Infect. Dis. 1995, 15:179-203.
71. Southwick F.S., Richardson E.P., Swartz M.N. Septic thrombosis of the dural venous sinuses. Medicine 1986, 65:82-106.
72. Spach D.H., Liles W.C., Campbell G.L., Quick R.E., Anderson D.E., Fritsche T.R. Tick-borne diseases in the United States. N. Engl. J. Med. 1993, 329:936-947.
73. Spataro V., Marone C. Rhabdomyolysis associated with bacteremia due to Streptococcus pneumoniae: Case report and reveiw. Clin. Infect. Dis. 1993, 17:1063-1064.
74. Swartz M.N. Bacterial meningitis. More involved than just the meninges. N. Engl. J. Med. 1984, 311:912-914.
75. Syrogiannopoulos G.A., Lourida A.N., Theodoridou M.C., Pappas I.G., Babilis G.C., Economidis J.J., Zoumboulakis D.J., Beratis N.G., Matsaniotis Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J. Infect. Dis. 1994, 169:853-858.
76. Syrogiannopoulos G.A., Olsen K.D., Reisch J.S., McCracken G.H. Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J. Infect. Dis. 1987, 155:213-219.
77. Täuber M.G., Khayam-Bashi H., Sande M.A. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J. Infect. Dis. 1985, 151:528-534.
78. Thomas R., Le Tulzo Y., Bouget J., et al. Trial of dexam-ethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Study Group. Intensive Care Med. 1999, 25:475-480.
79. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 1997, 24:S85-S88.
80. Treadwell T.A., Holman R.C., Clarke M.J., Krebs J.W., Paddock C.D., Cilds J.E. Rocky Mountain spotted fever in the United States, 1993-1996. Am. J. Trop. Med. Hyg. 2000, 63:21-26.
81. Tureen J.H., Dworkin R.J., Kennedy S.L., Sachdeva M., Sande M.A. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J. Clin. Invest. 1990, 85:577-581.
82. Viallon A., Zeni F., Lambert C., et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin. Infect. Dis. 1999, 28:1313-1316.
83. Weber J.R., Angstwurm K., Bûrger W., Einhäupl K.M., Dirnagl U. Anti ICAM-1 (CD54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J. Neuroimmunol. 1995, 63:63-68.
84. White B., Livingstone W., Murphy C., Hodgson A., Rafferty M., Smith O.W. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulmanans-associated meningococcemia. Blood 2000, 96:3719-3724.
85. WHO Control of epidemic meningococcal disease. WHO Practical Guidelines 2000, Internet WHO/EMC Web Site. 2nd ed.